Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy. Genes Dis. 2016 Dec; 3(4):252-256.
Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy.
Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant Melanoma. Genes Dis. 2018 Mar; 5(1):46-48.
Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant Melanoma.
Vaidya A, Hurwitz S, Yialamas M, Min L, Garg R
Improving the management of diabetes in hospitalized patients: the results of a computer-based house staff training program. Diabetes Technol Ther. 2012 Jul; 14(7):610-8.
Improving the management of diabetes in hospitalized patients: the results of a computer-based house staff training program.
Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Endocr Rev. 2019 02 01; 40(1):17-65.
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.
Babwah AV, Pampillo M, Min L, Kaiser UB, Bhattacharya M
Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin-induced signaling that is dependent upon an influx of extracellular Ca2+. Endocrinology. 2012 Dec; 153(12):5875-87.
Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin-induced signaling that is dependent upon an influx of extracellular Ca2+.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Association of ipilimumab therapy for advanced melanoma with secondary adrenal insufficiency: a case series. Endocr Pract. 2012 May-Jun; 18(3):351-5.
Association of ipilimumab therapy for advanced melanoma with secondary adrenal insufficiency: a case series.
Ma C, Hodi FS, Giobbie-Hurder A, Wang X, Zhou J, Zhang A, Zhou Y, Mao F, Angell TE, Andrews CP, Hu J, Barroso-Sousa R, Kaiser UB, Tolaney SM, Min L
The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders. Cancer Immunol Res. 2019 07; 7(7):1214-1220.
The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders.
Catalino MP, Meredith DM, De Girolami U, Tavakol S, Min L, Laws ER
Corticotroph hyperplasia and Cushing disease: diagnostic features and surgical management. J Neurosurg. 2021 07 01; 135(1):152-163.
Corticotroph hyperplasia and Cushing disease: diagnostic features and surgical management.
Wang F, Catalino MP, Bi WL, Dunn IF, Smith TR, Guo Y, Hordejuk D, Kaiser UB, Laws ER, Min L
The Journal of clinical endocrinology and metabolism
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab. 2021 01 01; 106(1):e94-e102.
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
Zhang AL, Wang F, Chang LS, McDonnell ME, Min L
Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis. Front Endocrinol (Lausanne). 2021; 12:620522.
Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis.
Cheung YM, Cromwell GE, Tolaney SM, Min L, McDonnell ME
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer. Breast Cancer Res Treat. 2022 Apr; 192(2):303-311.
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer.
Cheung YM, Hughes M, Harrod J, Files J, Kirkner G, Buckley L, Lin NU, Tolaney SM, McDonnell ME, Min L
The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer. J Clin Endocrinol Metab. 2022 08 18; 107(9):2511-2521.
The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer.
Hordejuk D, Cheung YM, Wang W, Smith T, Laws E, Kaiser UB, Min L
Long-Term Changes in the Size of Pituitary Microadenomas. Ann Intern Med. 2023 03; 176(3):298-302.
Long-Term Changes in the Size of Pituitary Microadenomas.
Harrod JC, Cheung YM, Buckley L, Cromwell GE, Fowler KM, Hughes ME, Lin NU, Tolaney SM, Min L, McDonnell ME
Diabetic medicine : a journal of the British Diabetic Association
Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer. Diabet Med. 2024 Apr; 41(4):e15292.
Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer.
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patients. Endocr Relat Cancer. 2024 Nov 01; 31(11).
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patients.
Hong CS, Chabros J, Kilgallon JL, Gerstl JVE, Omara C, Drexler R, Flitsch J, Ricklefs FL, Ryba AS, Mazzatenta D, Guaraldi F, Corrales CE, Min L, Smith TR
A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomas. Neurosurg Rev. 2024 Sep 28; 47(1):703.
A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomas.
Hong CS, Gerstl JVE, Maniar K, Kilgallon JL, Min L, Onnela JP, Corrales CE, Smith TR
Perioperative Mobility Assessment of Acromegalic Patients Undergoing Endoscopic Endonasal Resection of Pituitary Adenomas Using Digital Phenotyping. Front Horm Res. 2024; 55:215-225.
Perioperative Mobility Assessment of Acromegalic Patients Undergoing Endoscopic Endonasal Resection of Pituitary Adenomas Using Digital Phenotyping.
Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study. EClinicalMedicine. 2025 Jan; 79:102984.
Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study.
Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study. J Bone Metab. 2025 Feb; 32(1):38-48.
Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study.
Min L, Soltis K, Reis AC, Xu S, Kuohung W, Jain M, Carroll RS, Kaiser UB
Molecular endocrinology (Baltimore, Md.)
Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling. Mol Endocrinol. 2014 Jan; 28(1):16-27.
Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling.
Ipilimumab-induced autoimmune adrenalitis. Lancet Diabetes Endocrinol. 2013 Nov; 1(3):e15.
Ipilimumab-induced autoimmune adrenalitis.
Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis. Cancer Immunol Res. 2014 Jan; 2(1):15-8.
Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis.
Lin W, Shi S, Zheng Y, Laws E, Smith TR, Min L
Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):484-496.
Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly.
Ahow M, Min L, Pampillo M, Nash C, Wen J, Soltis K, Carroll RS, Glidewell-Kenney CA, Mellon PL, Bhattacharya M, Tobet SA, Kaiser UB, Babwah AV
KISS1R signals independently of Gaq/11 and triggers LH secretion via the ß-arrestin pathway in the male mouse. Endocrinology. 2014 Nov; 155(11):4433-46.
KISS1R signals independently of Gaq/11 and triggers LH secretion via the ß-arrestin pathway in the male mouse.
Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB
Clinical cancer research : an official journal of the American Association for Cancer Research
Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 Feb 15; 21(4):749-55.
Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.
Corticosteroids and immune checkpoint blockade. Aging (Albany NY). 2015 Aug; 7(8):521-2.
Corticosteroids and immune checkpoint blockade.
Min L, Leon S, Li H, Pinilla L, Carroll RS, Tena-Sempere M, Kaiser UB
RF9 Acts as a KISS1R Agonist In Vivo and In Vitro. Endocrinology. 2015 Dec; 156(12):4639-48.
RF9 Acts as a KISS1R Agonist In Vivo and In Vitro.
Min L, Nie M, Zhang A, Wen J, Noel SD, Lee V, Carroll RS, Kaiser UB
Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction. Neuroendocrinology. 2016; 103(3-4):230-9.
Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction.
Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
Bresler SC, Min L, Rodig SJ, Walls AC, Xu S, Geng S, Hodi FS, Murphy GF, Lian CG
Laboratory investigation; a journal of technical methods and pathology
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity. Lab Invest. 2017 02; 97(2):207-216.
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity.
Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy. Eur J Endocrinol. 2011 Feb; 164(2):303-7.
Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy.
Bi WL, Greenwald NF, Ramkissoon SH, Abedalthagafi M, Coy SM, Ligon KL, Mei Y, MacConaill L, Ducar M, Min L, Santagata S, Kaiser UB, Beroukhim R, Laws ER, Dunn IF
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors. Endocrinology. 2017 07 01; 158(7):2284-2291.
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.
Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018 Feb 01; 4(2):173-182.
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
Lee H, Hodi FS, Giobbie-Hurder A, Ott PA, Buchbinder EI, Haq R, Tolaney S, Barroso-Sousa R, Zhang K, Donahue H, Davis M, Gargano ME, Kelley KM, Carroll RS, Kaiser UB, Min L
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy. Cancer Immunol Res. 2017 12; 5(12):1133-1140.
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.
Barroso-Sousa R, Ott PA, Hodi FS, Kaiser UB, Tolaney SM, Min L
Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management. Cancer. 2018 03 15; 124(6):1111-1121.
Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.
Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SD, Min L, Plummer L, Cerrato F, De Guillebon A, Wu IH, Wahab F, Dwyer A, Kirsch S, Quinton R, Cheetham T, Ozata M, Ten S, Chanoine JP, Pitteloud N, Martin KA, Schiffmann R, Van der Kamp HJ, Nader S, Hall JE, Kaiser UB, Seminara SB
GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1771-81.
GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1.